Phase I/II Study of Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer.

Trial Profile

Phase I/II Study of Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 30 Jun 2014

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Gemcitabine
  • Indications Biliary cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 26 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 26 Feb 2013 Planned end date changed from 1 Nov 2015 to 1 Aug 2013 as reported by ClinicalTrials.gov.
    • 07 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top